µ¼¶Á
ÃÀ¹ú³¦Í⳦ÄÚÓªÑøÑ§»á£¨American Society for Parenteral and Enteral Nutrition, ASPEN£©ÊÇÁÙ´²ÓªÑøÁìÓò×î¾ßÓ°ÏìÁ¦µÄ¹ú¼ÊȨÍþѧÊõ×éÖ¯Ö®Ò»£¬ASPENÿÄêÕÙ¿ªÒ»´ÎѧÊõÄê»á£¬Ö¼ÔÚ´«²¥ÁÙ´²ÓªÑø»ù±¾ÖªÊ¶¼°·ÖÏíÁÙ´²ÓªÑø×îнøÕ¹£¬´Ó¶øÖ¸µ¼Êµ¼ù¡¢Íƶ¯ÁÙ´²ÓªÑøÊÂÒµµÄ·¢Õ¹¡£2023ÄêÃÀ¹ú³¦Í⳦ÄÚÓªÑøÑ§»áÓªÑø¿ÆÑ§Óëʵ¼ù´ó»á£¨ASPEN 2023£©ÓÚ4ÔÂ20ÈÕ~4ÔÂ23ÈÕÔÚÃÀ¹úÀ˹ά¼Ó˹¾ÙÐУ¬Ò½ÂöÍ¨ÌØß¢È¡´ó»áÉÏÏû»¯ÁìÓò×îÐÂÑо¿½øÕ¹½øÐб¨µÀ£¬Ï£Íû¶ÔÄúµÄÁÙ´²¹¤×÷ÓÐËù°ïÖú¡£
Ñо¿±³¾°
ÓëÑ×Ö¢ÐÔ³¦²¡ (Inflammatory Bowel Disease£¬IBD) »¼ÕßÓªÑø²»Á¼Ïà¹ØµÄ΢Á¿ÓªÑøËØÈ±·¦Ö¢£¨Micronutrient Deficiencies£©¿Éµ¼ÖÂһϵÁв¢·¢Ö¢£¬°üÀ¨Æ¶Ñª¡¢ÄýѪ¹¦ÄÜÕϰ¡¢ÇпÚÓúºÏ²»Á¼ºÍ½áÖ±³¦°©¡£±¾Ñо¿Ö¼ÔÚ̽¾¿ IBD »¼ÕßµÄ΢Á¿ÓªÑøËØÈ±·¦Ö¢£¨Î¬ÉúËØ A¡¢E¡¢K ºÍÍ£©£¬²¢Ç¿µ÷¹Ø×¢»¼ÕßµÄÖ¢×´»ò²¡Ê·ÌØÕ÷£¬ÒÔ°ïÖúʶ±ð΢Á¿ÓªÑøËØÈ±·¦Ö¢¡£
Ñо¿Éè¼Æ
¶Ô2013Äê1ÔÂÖÁ2017Äê6ÔÂÆÚ¼äÔÚÈý¼¶Ò½ÁÆÖÐÐÄסԺµÄICD-9/10±àÂëÕï¶ÏΪ¿ËÂÞ¶÷²¡£¨Crohn's disease ,CD£©»òÀ£ÑñÐԽ᳦Ñ×£¨ulcerative colitis ,UC£©µÄ³ÉÄ껼Õß½øÐлعËÐÔµç×Ó²¡ÀúÉó²é¡£
ÄÉÈë¾ßÓÐѪÇå»òȫѪ΢Á¿ÓªÑøËØË®Æ½µÄ³ÉÄ껼Õߣ¬²¢Ê¹ÓÃÿÖÖ΢Á¿ÓªÑøËصıê׼ѪÇå»òȫѪãÐÖµ¡£ÅųýÔи¾ºÍ±»¼à½ûµÄ»¼Õß¡£
Ñо¿½á¹û
¹²ÄÉÈë219ÃûIBD»¼Õߣ¨171ÀýCD£¬48ÀýUC£©¡£¶Ô²¿·ÖIBD »¼Õß½øÐÐÁË΢Á¿ÓªÑøËØÆÀ¹À£¨A£º53.2%£¬E£º29.6%£¬K£º25% ºÍÍ£º26.7%£©¡£ÕûÌå¶øÑÔ£¬34.7%»¼ÕßÓÐ΢Á¿ÓªÑøËØÈ±·¦Ö¢¡£CD»¼ÕßάÉúËØA¡¢E¡¢K ¼°Íȱ·¦Ö¢»¼ÕߵıÈÀý·Ö±ðΪ 25.4%¡¢23.7%¡¢29.4% ºÍ 25.4%£¬UC»¼Õß·Ö±ðΪ52.9%¡¢43.8%¡¢18.2% ºÍ 50%¡£Óë΢Á¿ÓªÑøËØÈ±·¦Ïà¹ØµÄ×î³£¼ûÖ¢×´»ò²¡Ê·ÌØÕ÷ÊÇÆ¤·ô¸ÉÔï¡¢½Ç»¯¹ý¶È¡¢ðþÑ÷¡¢Æµ·±¸ÐȾ¡¢Ñáʳ/ʳÓû²»Õñ/ÌåÖØÏ½µ£¬ CRPÉý¸ß(άÉúËØAȱ·¦)¡¢¼¡ÈâÎÞÁ¦ (άÉúËØEȱ·¦)¡¢³öѪ¡¢¹ÇÖÊÊèËÉ¡¢Ñª¹Ü¸Æ»¯Æ¶Ñª£¨Î¬ÉúËØKȱ·¦£©¡¢ÑªÐ¡°å¼õÉÙ¡¢Æ£ÀÍ¡¢¼¡ÎÞÁ¦È±·¦)¡£
ÈçͼËùʾ£¬Ñо¿Õß¶Ô²¿·Ö»¼Õß½øÐÐÁË΢Á¿ÓªÑøËزâÊÔ¡£¾ßÓÐÿÖÖȱÏݵϼÕßÊýÁ¿ÏÔʾÔÚµ×ÐÐÖÐ
Ñо¿½áÂÛ
΢Á¿ÓªÑøËØÈ±·¦ÔÚ IBD »¼ÕßÖкܳ£¼û£¬µ«Î´¶ÔÆä½øÐг£¹æÆÀ¹À¡£ÓÈÆäÊÇάÉúËØA¡¢E¡¢K ºÍÍȱ·¦£¬ÉÐδµÃµ½³ä·ÖÈÏʶ¡£IBD»¼Õß΢Á¿ÓªÑøËØÈ±·¦µÄÔÒò¿ÉÄܰüÀ¨ÎüÊÕ¼õÉÙ¡¢ÂýÐÔÑ×Ö¢¡¢ÉãÈë¼õÉÙ¡¢Ò©ÎïÏ໥×÷ÓúͼÈÍùÊÖÊõ¡£Ó¦¶ÔÏà¹ØµÄ²¡Ê·ÌØÕ÷ÒýÆð»³Òɲ¢¼°Ê±ÆÀ¹ÀºÍÖÎÁÆ¡£
²Î¿¼ÎÄÏ×£º
Amir Kamel,et al. Incidence of Micronutrient Deficiencies in Inflammatory Bowel Disease. ASPEN 2023 Abstract P45
ʵÑéÍâ°ü ÏëÁ˽â¸ü¶àÇë¹Ø×¢£º